Legal & General Group PLC Tango Therapeutics, Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 6,445 shares of TNGX stock, worth $52,655. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,445

Previous 6,985 7.73%

Holding current value

$52,655

Previous $35,000 54.29%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$4.96 - $8.53 $2,678 - $4,606	-540 Reduced 7.73%	6,445 $54,000
Q2 2025 Aug 12, 2025	BUY	$1.1 - $5.47 $1,804 - $8,970	1,640 Added 30.68%	6,985 $35,000
Q1 2025 May 15, 2025	SELL	$1.37 - $3.47 $44,683 - $113,177	-32,616 Reduced 85.92%	5,345 $7,000
Q4 2024 Feb 13, 2025	SELL	$2.79 - $7.46 $7,284 - $19,478	-2,611 Reduced 6.44%	37,961 $117,000
Q3 2024 Nov 14, 2024	SELL	$7.36 - $11.93 $883 - $1,431	-120 Reduced 0.29%	40,572 $312,000

Q2 2024 May 29, 2025	BUY	$6.66 - $10.15 $11,148 - $16,991	1,674 Added 4.6%	38,081 $326,000
Q2 2024 Aug 14, 2024	BUY	$6.66 - $10.15 $28,538 - $43,492	4,285 Added 11.77%	40,692 $349,000
Q1 2024 May 29, 2025	BUY	$7.51 - $12.88 $233,275 - $400,078	31,062 Added 581.14%	36,407 $289,000
Q4 2023 May 29, 2025	BUY	$6.52 - $12.01 $202,524 - $373,054	31,062 Added 581.14%	36,407 $360,000
Q4 2023 Feb 15, 2024	SELL	$6.52 - $12.01 $22,917 - $42,215	-3,515 Reduced 8.8%	36,407 $360,000
Q3 2023 Nov 14, 2023	SELL	$2.93 - $11.26 $1,910 - $7,341	-652 Reduced 1.61%	39,922 $449,000
Q2 2023 Aug 14, 2023	BUY	$2.67 - $4.7 $58,427 - $102,850	21,883 Added 117.08%	40,574 $134,000
Q1 2023 May 15, 2023	BUY	$3.76 - $8.06 $4,598 - $9,857	1,223 Added 7.0%	18,691 $73,000
Q4 2022 Feb 14, 2023	BUY	$3.41 - $8.29 $20,081 - $48,819	5,889 Added 50.86%	17,468 $126,000
Q3 2022 Nov 14, 2022	BUY	$3.25 - $5.46 $12,788 - $21,485	3,935 Added 51.48%	11,579 $42,000
Q2 2022 Aug 22, 2022	SELL	$3.86 - $8.01 $14,486 - $30,061	-3,753 Reduced 32.93%	7,644 $35,000
Q4 2021 Feb 14, 2022	BUY	$9.55 - $14.29 $108,841 - $162,863	11,397 New	11,397 $125,000

Others Institutions Holding TNGX

# of Institutions

147

Shares Held

130M

Call Options Held

170K

Put Options Held

17.6K

View Full List

About Tango Therapeutics, Inc.

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $720M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

More about TNGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Tango Therapeutics, Inc. Transaction History